Dr. Daniel S. Donovan JR., MD, MS
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- Icahn School of Medicine at Mount Sinai (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 157
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: Icahn School of Medicine at Mount Sinai
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
NY license 173575
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Beth Israel New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 157
- Services billed
- 429
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 237 | 114 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 69 | 15 |
| New patient office or other outpatient visit, 60-74 minutes | 27 | 27 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 26 | 19 |
| Established patient office or other outpatient visit, 30-39 minutes | 22 | 21 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ozempic (semaglutide) Other prescribers in New York, NY | 334 |
| Jardiance (empagliflozin) Other prescribers in New York, NY | 175 |
| Levothyroxine Sodium Other prescribers in New York, NY | 167 |
| Metformin Hcl Er (metformin hcl) Other prescribers in New York, NY | 104 |
| Synjardy Xr (empagliflozin/metformin hcl) Other prescribers in New York, NY | 100 |
| Janumet Xr (sitagliptin phos/metformin hcl) Other prescribers in New York, NY | 85 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in New York, NY | 79 |
| Synthroid (levothyroxine sodium) Other prescribers in New York, NY | 75 |
| Mounjaro (tirzepatide) Other prescribers in New York, NY | 70 |
| Novolog Flexpen (insulin aspart) Other prescribers in New York, NY | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 3 payments worth $131 in total to this clinician.
| Medtronic, Inc. | $101 |
|---|---|
| Novo Nordisk Inc | $29.72 |
| Food and Beverage | $131 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.